SCHEMBL10107215

SCHEMBL10107215

CCc1cccc(CNCC(C)C(=O)N(Cc2cc(Cl)c3c(c2)OCCCO3)CC(C)C)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PROKR2 Q8NFJ6 5/20 0.68
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MAPK8 P45983 1/20 0.35
GRIN2D O15399 1/20 0.32
GRIN3B O60391 1/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2A Q12879 1/20 0.32
GRIN2B Q13224 1/20 0.32
GRIN2C Q14957 1/20 0.32
GRIN3A Q8TCU5 1/20 0.32
ALDH1A1 P00352 2/20 0.32
USP2 O75604 1/20 0.31
TSHR P16473 1/20 0.31
BDKRB1 P46663 2/20 0.31
HDAC3 O15379 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC7 Q8WUI4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL564752 0.92 PROKR2 (0.68) PROKR2MAPK8MEN1KMT2A
SCHEMBL10107516 0.92 PROKR2 (0.68) PROKR2NPC1RAB9ASMN1; SMN2MAPK8
SCHEMBL10106938 0.92 PROKR2 (0.68) PROKR2NPC1RAB9ASMN1; SMN2MAPK8
SCHEMBL565594 0.92 PROKR2 (0.68) PROKR2NPC1RAB9AMAPK8NR1H4
SCHEMBL565524 0.91 PROKR2 (0.69) PROKR2NPC1RAB9ASMN1; SMN2MAPK8
SCHEMBL565109 0.91 PROKR2 (0.69) PROKR2NPC1RAB9ASMN1; SMN2MAPK8
SCHEMBL15693909 0.91 PROKR2 (0.69) PROKR2NPC1RAB9ASMN1; SMN2MAPK8
SCHEMBL565634 0.91 PROKR2 (0.67) PROKR2MAPK8
SCHEMBL565304 0.91 PROKR2 (0.67) PROKR2NPC1RAB9ASMN1; SMN2MAPK8
SCHEMBL564836 0.91 PROKR2 (0.67) PROKR2MAPK8BDKRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof PROKR2, PROKR1, GIPR PROKR2 1/4885NPC1 3472/4885RAB9A 1704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.